Vitiligo Treatment by Targeting TYK2 Mediated Responses
Vitiligo Treatment by Targeting TYK2 Mediated Responses
Active, not recruiting · NCT06327321 · Registry updated 2026-05-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vitiligo Treatment by Targeting TYK2 Mediated Responses | Skin and Connective Tissue Diseases, hypopigmentation of the skin, skin disorder, skin pigmentation disorder, vitiligo | Active, not recruiting | Phase 2 | 2026-05-20 | NCT06327321 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Hospitalier Universitaire de Nice | 229 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| APHP, Henri Mondor | Paris | France | 1 |
| CHU de Bordeaux | Bordeaux | France | 1 |
| CHU de Lille | Lille | France | 38 |
| CHU de Nice - Hôpital de l'Archet | Nice | France | 9 |
| HCL | Lyon | France | 13 |